-
I129263-100gProduct Describtion:Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.An angiotensin II type 1 (AII1)-receptor antagonist.Product Application:Irbesartan has been
-
I129263-1gProduct Describtion:Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.An angiotensin II type 1 (AII1)-receptor antagonist.Product Application:Irbesartan has been
-
I129263-25gProduct Describtion:Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.An angiotensin II type 1 (AII1)-receptor antagonist.Product Application:Irbesartan has been
-
I129263-5gProduct Describtion:Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.An angiotensin II type 1 (AII1)-receptor antagonist.Product Application:Irbesartan has been
-
I127961-100mgIrinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
-
I127961-1gIrinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
-
I127961-500mgIrinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.Irinotecan hydrochloride has been used:in combination with 5-fluorouracil for screening growth inhibitory functionality in
-
K426875-1mlSLx-2119(KD-025) is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM: >: 200 fold selecivity over ROCK1(IC50 =24 uM).
-
S127897-100mgSLx-2119(KD-025) is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM: >: 200 fold selecivity over ROCK1(IC50 =24 uM).
-
S127897-10mgSLx-2119(KD-025) is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM: >: 200 fold selecivity over ROCK1(IC50 =24 uM).
-
S127897-250mgSLx-2119(KD-025) is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM: >: 200 fold selecivity over ROCK1(IC50 =24 uM).
-
S127897-25mgSLx-2119(KD-025) is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM: >: 200 fold selecivity over ROCK1(IC50 =24 uM).